An international commission made the case for focusing on body fat quantity and the illnesses people experience.

The NAPA Reauthorization Act extends the National Alzheimer's Plan through 2035, prioritizing healthy aging, risk reduction, ...

It’s not easy to become a taxi driver in London. Since 1865, to operate a taxi, drivers have had to pass what’s known as “the ...

Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...

This partnership marks a significant step in leveraging the power of AI to enhance clinical trial outcomes. Perceiv AI's AD-Px™ engine, known for its ability to forecast disease progression in ...

ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and ...

Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...

A new blood test may be key to uncovering new Alzheimer's disease therapies, allowing patients to be treated before the ...

DEMENTIA risk may start accumulating as early as childhood, experts have warned. A child’s body mass index (BMI), blood pressure and physical activity levels have been linked to changes in ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...